Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Epirazole

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

125 API Suppliers, 42 USDMF, 38 CEP/COS, 9 JDMF, 18 EU WC, 24 KDMF, 33 NDC API, 2 VMF, 60 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

29 Intermediate Suppliers

29 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1020 FDF Dossiers, 96 FDA Orange Book, 571 Europe, 11 Canada, 115 Australia, 40 South Africa, 187 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 20MG, CAPSULE;ORAL - 20MG;1.1GM, CAPSULE;ORAL - 40MG;1.1GM, TABLET, DELAYED RELEASE;ORAL - 20MG, CAPSULE;ORAL - 20MG;1.1GM, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 5 Rochem International Inc, 21 SPI Pharma, 15 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 40 BASF, 1 Bioplus Life Sciences, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 4 Finar, 13 Gangwal Chemicals, 14 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 38 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 78 Coating Systems & Additives, 48 Controlled & Modified Release, 43 Disintegrants & Superdisintegrants, 43 Thickeners and Stabilizers, 42 Solubilizers, 38 Direct Compression, 36 Granulation, 31 Taste Masking, 28 Topical, 27 Lubricants & Glidants, 23 Film Formers & Plasticizers, 22 Co-Processed Excipients, 22 Chewable & Orodispersible Aids, 20 Parenteral, 10 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

84 News #PharmaBuzz

84 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 523 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

63 APIs, 71 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

14 US Patents, 23 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 43 Others

ANALYTICAL

3 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Metrochem API Private Limited	India	M/s Metrochem API Private Limited	WC-0493	Omeprazole USP/Ph.Eur.	2024-04-03	2027-01-21	Unit-IV, Plot No: 34B, 40B & 60B, J.N. Pharma City, Thanam (V), Parawada (M), Anakapalli District -531021, Andhra Pradesh, India
04/06/2025	Dr. Reddy's Laboratories	India	M/s Dr. Reddys Laboratories Limited	WC-0035	Omeprazole Ph. Eur.	2022-05-26	2025-06-25	Unit-lll, Plot No. 116, Sri Venkateswara Co-operative, Industrial Estate, IDA, Bollaram (V), Jinnaram (M), Sangareddy (Dist.), Telangana State, India

Epirazole

Epirazole

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

125 API Suppliers

42 USDMF

38 CEP/COS

9 JDMF

18 EU WC

24 KDMF

33 NDC API

2 VMF

60 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

29 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1020 FDF Dossiers

96 FDA Orange Book

571 Europe

11 Canada

115 Australia

40 South Africa

187 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 20MG

CAPSULE;ORAL - 20MG;1.1GM

CAPSULE;ORAL - 40MG;1.1GM

TABLET, DELAYED RELEASE;ORAL - 20MG

CAPSULE;ORAL - 20MG;1.1GM

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Evonik

5 Rochem International Inc

21 SPI Pharma

15 DKSH

2 Pharm-RX Chemical

9 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 ACG Worldwide

9 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

40 BASF

1 Bioplus Life Sciences

15 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

4 Finar

13 Gangwal Chemicals

14 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

38 Kerry

4 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

3 Novo Excipients

5 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons